HomeDXCM • NASDAQ
DexCom Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 1.11B | 7.64% |
Operating expense | 466.90M | 6.19% |
Net income | 151.70M | -40.81% |
Net profit margin | 13.62 | -45.04% |
Earnings per share | 0.45 | -10.00% |
EBITDA | 246.70M | -8.43% |
Effective tax rate | 28.21% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.58B | -5.31% |
Total assets | 6.48B | 3.51% |
Total liabilities | 4.38B | 4.43% |
Total equity | 2.10B | — |
Shares outstanding | 390.77M | — |
Price to book | 13.15 | — |
Return on assets | 7.36% | — |
Return on capital | 10.19% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 151.70M | -40.81% |
Cash from operations | 301.40M | 125.60% |
Cash from investing | -303.70M | -173.20% |
Cash from financing | -1.60M | 99.75% |
Net change in cash | -15.10M | 80.47% |
Free cash flow | 143.20M | 354.35% |
Previous close
$70.76
Day range
$68.30 - $70.72
Year range
$62.34 - $142.00
Market cap
27.01B USD
Avg Volume
3.95M
P/E ratio
49.49
Dividend yield
-
Primary exchange
NASDAQ
About
DexCom, Inc. is an American healthcare company that develops, manufactures, produces, and distributes continuous glucose monitoring systems for diabetes management. It operates internationally with headquarters in San Diego, California; and has manufacturing facilities in Mesa, Arizona; Batu Kawan, Malaysia; and Athenry, Ireland. Wikipedia
Founded
1999
Headquarters
Website
Employees
10,250
